Novel GPR120 agonist TUG891 modulates fat taste perception and preference and activates tongue-brain-gut axis in mice

Novel GPR120 agonist TUG891 modulates fat taste perception and preference and activates tongue-brain-gut axis in mice

GPR120 is implicated as a lipid receptor in the oro-sensory detection of dietary fatty acids. However, the effects of GPR120 activation on dietary fat intake or obesity are not clearly understood. We investigated to determine whether the binding of TUG891, a novel GPR120 agonist, to lingual GPR120 m...

Full description

Bibliographic Details
Main Authors:	Babar Murtaza, Aziz Hichami, Amira S. Khan, Bharat Shimpukade, Trond Ulven, Mehmet Hakan Ozdener, Naim A. Khan
Format:	Article
Language:	English
Published:	Elsevier 2020-02-01
Series:	Journal of Lipid Research
Subjects:	linoleic acid extracellular signal-regulated kinase 1/2 glucagon-like peptide-1 obesity
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520435321

Similar Items

The GPR120 agonist TUG‐891 promotes metabolic health by stimulating mitochondrial respiration in brown fat
by: Maaike Schilperoort, et al.
Published: (2018-03-01)

The GPR120 Agonist TUG-891 Inhibits the Motility and Phagocytosis of Mouse Alveolar Macrophages
by: Xing-Li Su, et al.
Published: (2020-01-01)

Activation of GPR120 by TUG891 ameliorated cisplatin-induced acute kidney injury via repressing ER stress and apoptosis
by: Zhuo Huang, et al.
Published: (2020-06-01)

Implication of Ca2+ signaling in fat taste perception : modulation by planttriterpenoids and a chemical GPR120 agonist
by: Murtaza, Babar
Published: (2019)

Fatty Acid Lingual Application Activates Gustatory and Reward Brain Circuits in the Mouse
by: Yvan Peterschmitt, et al.
Published: (2018-09-01)

<i>CD36</i> and <i>GPR120</i> Methylation Associates with Orosensory Detection Thresholds for Fat and Bitter in Algerian Young Obese Children
by: Moustafa Berrichi, et al.
Published: (2020-06-01)

Glucagon Shows Higher Sensitivity than Insulin to Grapeseed Proanthocyanidin Extract (GSPE) Treatment in Cafeteria-Fed Rats
by: Carme Grau-Bové, et al.
Published: (2021-03-01)

Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist
by: Kaare V. Grunddal, et al.
Published: (2021-07-01)

Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors
by: Jonas Ronn, et al.
Published: (2017-12-01)

Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date
by: Howell R, et al.
Published: (2019-04-01)

Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy
by: V.L. Orlenko, et al.
Published: (2014-05-01)

New Potential Targets of Glucagon-Like Peptide 1 Receptor Agonists in Pancreatic β-Cells and Hepatocytes
by: Won-Young Lee
Published: (2017-02-01)

The associations of incretin hormone concentration with gestational diabetes mellitus
by: Tatiana V. Saprina, et al.
Published: (2016-04-01)

New uses and formulations of glucagon for hypoglycaemia
by: Pilar I Beato-Víbora, et al.
Published: (2019-07-01)

Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes
by: Scott A. Campbell, et al.
Published: (2020-09-01)

Partners for life
by: Lena Eliasson, et al.
Published: (2016-05-01)

Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist
by: Nicolas Damond, et al.
Published: (2016-04-01)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
by: Marta Seghieri, et al.
Published: (2018-11-01)

The Peutz-Jeghers kinase LKB1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage in mice
by: Sagen Zac-Varghese, et al.
Published: (2014-11-01)

Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patients
by: Dan Kawamori, et al.
Published: (2019-01-01)

Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells
by: Yun Kyung Jeon, et al.
Published: (2014-12-01)

In vitro and in vivo effects of exendin-4 on human islet amyloid polypeptide induced beta-cell dysfunction.
Published: (2013)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
by: Takaaki Murakami, et al.
Published: (2020-11-01)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
by: Soyeon Yoo, et al.
Published: (2021-06-01)

Incretins today: multiple effects and therapeutic potential
by: Oksana V. Tsygankova, et al.
Published: (2019-04-01)

The Essential Role of Pancreatic α-Cells in Maternal Metabolic Adaptation to Pregnancy
by: Dzyuba, B., et al.
Published: (2022)

The deletion of glucagon-like peptide-1 receptors expressing neurons in the dorsomedial hypothalamic nucleus disrupts the diurnal feeding pattern and induces hyperphagia and obesity
by: Yuko Maejima, et al.
Published: (2021-06-01)

The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment
by: Baocheng Xie, et al.
Published: (2021-06-01)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
by: Yu Mi Kang, et al.
Published: (2016-06-01)

A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor
by: Noura Al-Zamel, et al.
Published: (2019-07-01)

Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
by: Dan Kawamori, et al.
Published: (2020-03-01)

A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia
by: Carolina B. Lobato, et al.
Published: (2020-11-01)

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
by: Gagik R. Galstyan, et al.
Published: (2017-10-01)

Secretion of incretin hormones in people having risk factors for type 2 diabetes mellitus
by: E A Shestakova, et al.
Published: (2014-10-01)

Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammation
by: Nathalia R. V. Dragano, et al.
Published: (2017-04-01)

GLP-1(7-36) inhibits atherosclerosis progression in ApoE-/- mouse aorta by lowering expressions of CD36 and ACAT1 in foam cells
by: HAN Yongkui, et al.
Published: (2019-10-01)

Effects of exercise on glucagon-like peptide-1 (GLP-1)
by: Shin-ya Ueda, et al.
Published: (2013-06-01)

Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications
by: Meike eKörner, et al.
Published: (2012-12-01)

Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed mice
by: Flatt, P.R, et al.
Published: (2022)

Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity
by: Ekaterina V. Tikhonenko, et al.
Published: (2019-03-01)

Cannot write session to /tmp/vufind_sessions/sess_m8qbq23qh4a2dnb77djajme442